Wow, I just noticed how MAMA closed yesterday. The shorts are really getting squeezed there. It’s like a flashback to 2004. I wonder if Mark Cuban has bought back in. 
I decided early yesterday, while watching paint dry that I was done for the week. Good luck if you’re stepping into the fray the rest of the week… and watch out for that Philly Fed report hitting at noon.
On Today’s Calendar:
- 10:00 — Leading Indicators
- 12:00 — Philadelphia Fed
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
Gapping down on disappointing earnings/guidance: IAAC -32% (down in sympathy: GROW -4.3%), WOR -11%, JBL -7% (also downgrades from Credit Suisse and Jefferies), FDC -5.4% (guidance only), CMC -3.7%, BBBY -2.9% (also Credit Suisse downgrade), PMCS -2.8% (guidance only)… Other News: SOFO -13% (prices offering), SIGA -9% (profit taking after big move), HBAN -5.3% (announces merger with SKYF), DIVX -4.7% (Cramer negative on Mad Money), TSTC -4.2%, WTSLA -3.3% (provides Dec same store guidance), MA -1.8% (HSBC downgrade).
Gapping Up
PRCS +145% (to be acquired by GSK), DPHIQ.PK +38% (hedge fund proposes reorganization), HORC +20% (to be acquired), SKYF +16% (announces merger), PNTR +15% (gudies higher; sees acquisitions), MAMA +9% (momentum continues; stock up nearly 200% in two weeks since announcing it acquired a video search site), DEPO +11% (announces litigation victory against Ivax), RPRX +9% (positive clinical data), ESCL +8.6% (extends momentum, stock +130% in two days, short squeeze), NSTK +7% (positive clinical data), ELOS +6.8% (Cramer bullish on Mad Money; see our profile from yesterday), ANIK +6.3% (gets FDA approval), CAG +5.6% (reports NovQ), ACN +5.1% (reports strong NovQ, guides higher; also upgrades from Baird and RBC), SEPR +5.5% (following positive CMS news yesterday, Deutsche raises tgt to $75), RIO +2.4% (announces iron ore prices for Chinese steelmaker – Reters), BSX +1.3% (Cleveland Clinic signs agreement to buy only BSX stents – CNBC), LVLT +1.1%, SAP +1.1%… Under $3: ONSM +51% (up on Apple speculation), SYNX +45% (announces new contract), TUTS +16% (to be acquired by MOT), ENMD +8% (positive clinical data), MEMY +5.6%.
Disclaimer & How I use this list
